Abstracts by key term: Pharmacies
Schutzimpfungen in Apotheken sind in vielen Ländern seit Langem etabliert. In Deutschland ist die Grippeschutzimpfung in Apotheken seit 2022 erlaubt. Die Grippeschutz-Impfquote lag 2023 in Deutschland in der Risikogruppe der über 65-Jährigen mit 40,4% unter dem Durchschnitt der EU-27 (47,1%) und der in Irland erreichten Impfquote von 75,7%. Der Beitrag vergleicht Impfungen und die Erweiterung von Impfbefugnissen in Apotheken in Frankreich, Irland und der Schweiz mit der Situation in Deutschland. Auch wenn die Erteilung von Impfberechtigungen für Apothekerinnen und Apotheker nicht automatisch eine Erhöhung der Impfquoten nach sich zieht, zeigen die Daten am Beispiel Irlands, dass sie eine Voraussetzung für deren Erhöhung sind. Denn ein erheblicher Teil insbesondere der jüngeren und erwerbstätigen Bevölkerung wird dort in Apotheken geimpft, während Personengruppen mit altersbedingt höherer Zahl von Arztkontakten vorwiegend durch Hausärzte geimpft werden. In allen untersuchten Ländern wurden mit Grippeschutzimpfungen und der Erweiterung der Impfberechtigung auf weitere Impfstoffe in Apotheken positive Erfahrungen gemacht, dies ist auch für Deutschland zu erwarten.
31.01.2026
Since 2009, Germany has experienced a decline in the number of community pharmacies, prompting the Bavarian State Ministry of Health, Care and Prevention (StMGP) to commission a project to analyze pharmacy supply in Bavaria, which is being supported by the Bavarian State Office for Health and Food Safety (LGL) in technical and administrative terms. One subproject is concerned with estimating the demand for pharmacies and pharmacy staff based on routine data from statutory health insurance. In order to capture specific features of the pharmacy market relevant to the demand estimate, seven semi-structured interviews were conducted with stakeholders in self-governing organizations and service providers and then inductively coded. Overall, the experts considered the number of medicines dispensed at the expense of the statutory health insurance fund to be a suitable indicator for quantifying a pharmacy's services. However, they recommended considering certain additional services, such as the dispensing of over-the-counter medicines or other time-consuming activities such as the preparation of prescriptions or cytostatic drugs. Furthermore, the experts considered it sensible to consider all community pharmacies, regardless of their supplementary care mandate. Due to the multitude of influencing factors, the staffing of pharmacies was described as highly individual, and a distinction between prescribing activities by pharmaceutical technicians and licensed pharmacists was considered complex. The experts also emphasized the importance of accessibility for demand estimation and considered time frames of up to 30 minutes to be the maximum reasonable. As an alternative approach to demand estimation, the interviewees assessed determining a ratio of residents that a pharmacy can serve as difficult to quantify ad hoc and also highly dependent on population- and pharmacy-related factors. To counteract the potential undersupply in individual regions identified by the demand estimation, the respondents particularly advocated financial incentives. The majority of the experts surveyed supported the proposed method of estimating needs and were able to provide additional valuable insights by highlighting the specific features of the pharmacy market.